Cell and gene therapy: the impact of skills gaps in a fast-growing sector
Cell and gene therapy is a rapidly evolving experimental space that saw almost £20bn in funding last year. Despite growing investment in the sector, skills gaps have resulted in a...
AstraZeneca must emphasise benefit of Covid-19 vaccination, despite risk of rare blood clots
The European Medicines Agency (EMA) has confirmed a possible link between very rare cases of unusual blood clots after vaccination with the AstraZeneca Covid-19 vaccine, Vaxzevria. The EMA emphasised that…